Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-055948

EVP, Chief Development Officer bought 50,000 shares at $0.94 ($46,995)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Forbes William P EVP, Chief Development Officer 2023-11-16 Purchase +50,000 $0.94 $46,995 54,000 D
Open-market purchases · 50,000 sh · avg $0.94 · $46,995
Loading xslF345X05/doc4.xml…